Levels to trade Chart provides levels to trade. Price is always between two of them.Trade level to level.
−0.00GBP
−8.27 MGBP
475.00 KGBP
242.45 M
About E-THERAPEUTICS PLC ORD GBP0.001
Sector
Industry
CEO
Ahmad Ali Mortazavi
Website
Headquarters
London
Founded
2001
ISIN
GB00B2823H99
FIGI
BBG000R6HLH3
e-Therapeutics Plc, is a drug discovery and development company, which engages in the provision of evaluation services to investors and pharmaceutical companies. The company focuses on the therapeutic immune-oncology, addressing drug resistance in targeted cancer therapies and antivirals. It offers the following variety of preclinical stage assets: ETS2300, telomerase inhibition in anti-cancer; ETS3100, small molecule anti-TNFa; ETS2400, Hedgehog pathway inhibition; and ETS5200, broad spectrum antivirals together with two immuno-oncology checkpoint projects. The company was founded by Malcolm Philip Young on October 15, 2001 and is headquartered in London, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ETX is 9.95 GBX — it has decreased by 2.45% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange E-THERAPEUTICS PLC ORD GBP0.001 stocks are traded under the ticker ETX.
E-THERAPEUTICS PLC ORD GBP0.001 is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
ETX stock is 6.81% volatile and has beta coefficient of −2.42. Check out the list of the most volatile stocks — is E-THERAPEUTICS PLC ORD GBP0.001 there?
Yes, you can track E-THERAPEUTICS PLC ORD GBP0.001 financials in yearly and quarterly reports right on TradingView.
ETX stock has fallen by 18.79% compared to the previous week, the month change is a 23.46% fall, over the last year E-THERAPEUTICS PLC ORD GBP0.001 has showed a 23.46% decrease.
ETX net income for the last quarter is −5.59 M GBP, while the quarter before that showed −4.46 M GBP of net income which accounts for −25.37% change. Track more E-THERAPEUTICS PLC ORD GBP0.001 financial stats to get the full picture.
Today E-THERAPEUTICS PLC ORD GBP0.001 has the market capitalization of 59.60 M, it has increased by 7.44% over the last week.
No, ETX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ETX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade E-THERAPEUTICS PLC ORD GBP0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So E-THERAPEUTICS PLC ORD GBP0.001 technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating E-THERAPEUTICS PLC ORD GBP0.001 stock shows the strong sell signal. See more of E-THERAPEUTICS PLC ORD GBP0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. E-THERAPEUTICS PLC ORD GBP0.001 EBITDA is −12.16 M GBP, and current EBITDA margin is −2.06 K%. See more stats in E-THERAPEUTICS PLC ORD GBP0.001 financial statements.